Emicizumab in two patients with acquired haemophilia A – case report
Patients with acquired haemophilia A (PwAHA) can present with severe bleeding and may require lengthy treatment with bypassing agents and immunosuppression. We present two cases of the implementation of emicizumab in PwAHA. The first patient, an 82-year-old man with rheumatoid arthritis (RA), presen...
Saved in:
Main Authors: | Zhao Milly, Kartika Thomas, Witenko Corey, Snead Jessica, DeSancho Maria T, Ciolek Alana |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2024-08-01
|
Series: | The Journal of Haemophilia Practice |
Subjects: | |
Online Access: | https://doi.org/10.2478/jhp-2024-0016 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A single centre experience with clinical use of Neria™ Guard as mode of pain and distress management in the administration of emicizumab in children
by: Birkedal Maj Friberg
Published: (2024-12-01) -
The changing landscape of treatment for acquired hemophilia A
by: Massimo Franchini, et al.
Published: (2025-01-01) -
Living, Caring, Learning - Building family relationships in haemophilia care
by: Shoemark Robyn
Published: (2024-02-01) -
CATCH 2023 Meeting Summary: Collaborate & Address Treatment Challenges in Haemophilia
by: Benson Gary, et al.
Published: (2024-04-01) -
Retrospective study of spontaneous subarachnoid haemorrhage: vasospasm and other complications (Part III)
by: S. Bakanauskaitė, et al.
Published: (2023-10-01)